Clinical Trials
Learn how clinical trials work, eligibility, phases, safety profiles, and how to find opportunities for your condition.
Key Takeaways
- A clinical trial is a research study that tests new medical treatments in people to determine safety and effectiveness before they become widely available.
- Trials progress through 4 phases: Phase I (safety, 20-100 people), Phase II (effectiveness, 100-300), Phase III (comparison, 1,000-3,000), Phase IV (post-approval monitoring).
- Participation is voluntary — you can withdraw at any time without penalty or effect on your regular care.
- Study treatments and related tests are provided at no cost; many trials also compensate for time and travel.
What Is a Clinical Trial?
A clinical trial is a research study that tests new treatments, drugs, devices, or procedures in people to determine their safety and effectiveness. Clinical trials are the primary way that new medical treatments move from the laboratory to patients. Every FDA-approved drug, device, and biologic on the market today went through clinical trials before becoming available. These studies follow strict scientific and ethical guidelines, are overseen by Institutional Review Boards (IRBs), and are registered on ClinicalTrials.gov, a public database maintained by the National Library of Medicine.
What Are the 4 Phases of Clinical Trials?
Phase I
Tests safety and dosage in a small group of participants (20-100 people).
Phase II
Tests effectiveness and side effects in a larger group (100-300 people).
Phase III
Compares new treatment to standard treatment in large groups (1,000-3,000 people).
Phase IV
Post-approval studies to monitor long-term safety and effectiveness.
Who Is Eligible for a Clinical Trial?
Each clinical trial has specific inclusion and exclusion criteria that determine who can participate. Common eligibility factors include age, sex, type and stage of disease, previous treatments received, and overall health status. These criteria exist to ensure participant safety and to produce scientifically valid results.
Inclusion criteria define who the trial is designed for — for example, "adults aged 18-65 with stage II breast cancer." Exclusion criteria identify conditions that would make participation unsafe or compromise the study — such as pregnancy, certain medications, or other active medical conditions. Health Pioneer's trial matching tool pre-screens your eligibility before you contact research teams, saving time for both patients and investigators.
Are Clinical Trials Safe?
Clinical trials are regulated by the FDA and monitored by independent ethics committees called Institutional Review Boards (IRBs). Every trial must obtain informed consent, meaning participants receive detailed information about the study's purpose, procedures, potential risks, and expected benefits before agreeing to participate.
Participants can withdraw from a trial at any time, for any reason, without penalty or effect on their regular medical care. Safety monitoring occurs throughout the trial, and a Data Safety Monitoring Board (DSMB) can halt a study early if safety concerns arise. Learn more about your rights as a clinical trial participant.
Beyond Clinical Trials
In addition to traditional clinical trials, patients can explore emerging therapies including gene therapy, immunotherapy, mRNA treatments, and precision medicine approaches. Many of these breakthrough treatments are progressing rapidly through the trial process and may soon become standard care.
Ready to Find Trials?
Get personalized matching based on your condition and location.
Get Personalized Matching